Member of the Association of American Physicians
His primary scientific interests are in Internal medicine, Framingham Heart Study, Risk factor, Endocrinology and Framingham Risk Score. The various areas that Peter W.F. Wilson examines in his Internal medicine study include Diabetes mellitus and Cardiology. His biological study spans a wide range of topics, including Obesity and Vascular disease.
His Framingham Heart Study research includes elements of Relative risk, Stroke, Proportional hazards model, Prospective cohort study and Cohort. His Risk factor research includes themes of Odds ratio, Body mass index, Surgery, Epidemiology and Kidney disease. His Framingham Risk Score research is multidisciplinary, relying on both Intermittent claudication and Logistic regression.
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Framingham Heart Study, Framingham Risk Score and Risk factor. His Internal medicine study incorporates themes from Diabetes mellitus and Cardiology. His Diabetes mellitus research integrates issues from Obesity and Disease.
The Cardiology study combines topics in areas such as Stroke and Left ventricular hypertrophy. His Framingham Heart Study study which covers Proportional hazards model that intersects with Hazard ratio. His research in Risk factor intersects with topics in Odds ratio, Epidemiology, Surgery, Vascular disease and Heart disease.
His primary areas of investigation include Internal medicine, Diabetes mellitus, Cardiology, Blood pressure and Disease. The Internal medicine study which covers Endocrinology that intersects with Gene expression. In his study, Progenitor cell, CXCR4 and CD34 is strongly linked to Gastroenterology, which falls under the umbrella field of Diabetes mellitus.
His study looks at the relationship between Cardiology and topics such as Stroke, which overlap with Kidney disease. Peter W.F. Wilson interconnects Genetic analysis, Environmental health, Renal function, Population study and Retrospective cohort study in the investigation of issues within Blood pressure. Peter W.F. Wilson has researched Disease in several fields, including Familial hypercholesterolemia, Genome-wide association study, Bioinformatics, Risk allele and Apolipoprotein L1.
Peter W.F. Wilson mainly focuses on Internal medicine, Genome-wide association study, Disease, Genetics and Genetic architecture. His Internal medicine research incorporates themes from MEDLINE and Cardiology. His work deals with themes such as Biomarker, Kidney stones and Kidney, Kidney metabolism, which intersect with Genome-wide association study.
His Disease study combines topics in areas such as Risk allele, Apolipoprotein L1, Increased risk and Bioinformatics. Proportional hazards model is closely connected to Myocardial infarction in his research, which is encompassed under the umbrella topic of Lower risk. Peter W.F. Wilson has included themes like Case-control study, Mace and Risk factor in his Cause of death study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J Stone;Jennifer G Robinson;Alice H. Lichtenstein;C Noel Bairey Merz.
Prediction of Coronary Heart Disease Using Risk Factor Categories
Peter W. F. Wilson;Ralph B. D’Agostino;Daniel Levy;Albert M. Belanger.
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.
Mark J. Sarnak;Andrew S. Levey;Anton C. Schoolwerth;Josef Coresh.
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
David C. Goff;Donald M. Lloyd-Jones;Glen Bennett;Sean Coady.
Journal of the American College of Cardiology (2014)
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Sudha Seshadri;Alexa Beiser;Jacob Selhub;Paul F Jacques.
The New England Journal of Medicine (2002)
Forecasting the Future of Cardiovascular Disease in the United States A Policy Statement From the American Heart Association
Paul A. Heidenreich;Justin G. Trogdon;Olga A. Khavjou;Javed Butler.
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels: The Framingham Study
William P. Castelli;Robert J. Garrison;Peter W. F. Wilson;Robert D. Abbott.
Obesity and the Risk of Heart Failure
Satish Kenchaiah;Jane C Evans;Daniel Levy;Peter W F Wilson.
The New England Journal of Medicine (2002)
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.
Ralph B. D'Agostino;Ralph B. D'Agostino;Scott M Grundy;Lisa M. Sullivan;Lisa M. Sullivan;Peter Wilson;Peter Wilson.
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Jacob Selhub;Paul F. Jacques;Peter W. F. Wilson;David Rush.
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: